Acadia Pharmaceuticals (ACAD) Shares Outstanding (2016 - 2024)
Historic Shares Outstanding for Acadia Pharmaceuticals (ACAD) over the last 16 years, with Q4 2024 value amounting to $166.7 million.
- Acadia Pharmaceuticals' Shares Outstanding rose 125.03% to $166.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $166.7 million, marking a year-over-year increase of 125.03%. This contributed to the annual value of $166.7 million for FY2024, which is 125.03% up from last year.
- Per Acadia Pharmaceuticals' latest filing, its Shares Outstanding stood at $166.7 million for Q4 2024, which was up 125.03% from $164.7 million recorded in Q4 2023.
- In the past 5 years, Acadia Pharmaceuticals' Shares Outstanding ranged from a high of $166.7 million in Q4 2024 and a low of $159.6 million during Q4 2020
- Moreover, its 5-year median value for Shares Outstanding was $162.1 million (2022), whereas its average is $162.8 million.
- In the last 5 years, Acadia Pharmaceuticals' Shares Outstanding soared by 280.95% in 2020 and then skyrocketed by 65.35% in 2022.
- Over the past 5 years, Acadia Pharmaceuticals' Shares Outstanding (Quarter) stood at $159.6 million in 2020, then rose by 0.86% to $161.0 million in 2021, then grew by 0.65% to $162.1 million in 2022, then rose by 1.6% to $164.7 million in 2023, then increased by 1.25% to $166.7 million in 2024.
- Its Shares Outstanding was $166.7 million in Q4 2024, compared to $164.7 million in Q4 2023 and $162.1 million in Q4 2022.